Skip to content

Concurrent vaginal dinoprostone and oxytocin infusion versus oxytocin infusion for labour induction in term nulliparous with prelabour rupture of membranes: a randomised placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74376345
Enrollment
106
Registered
2007-11-16
Start date
2007-11-10
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prelabour rupture of membranes Pregnancy and Childbirth Prelabour rupture of membranes

Interventions

Vaginal dinoprostone and oxytocin infusion versus vaginal placebo and oxytocin infusion to induce labour. Women randomised to concurrent oxytocin infusion and prostaglandin will receive a single dose

Sponsors

University of Malaya Medical Centre (Malaysia)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Ruptured membranes confirmed clinically by demonstration of pooling of liquor at upper vagina on speculum assessment 2. Nulliparous (no previous delivery greater than 20 weeks) 3. Term gestation (greater than 36 weeks) 4. Bishop score on recruitment less than or equal to 6 5. Less than 1 contraction in 15 minutes 6. Singleton foetus 7. Cephalic presentation 8. Reassuring cardiotocogram

Exclusion criteria

Exclusion criteria: 1. Previous uterine incision 2. Meconium stained liquor at trial entry 3. Gross foetal anomaly 4. Asthma 5. Allergy to prostaglandin

Design outcomes

Primary

MeasureTime frame
Primary outcomes will be measured at or soon after delivery: 1. Proportion delivered vaginal delivery within 12 hours of commencement of induction of labour 2. Maternal satisfaction with the birth process using a 10 point visual analog scale

Secondary

MeasureTime frame
Secondary outcomes are intrapartum events, peri-delivery events and the "last" secondary outcome (occurence of maternal fever) will be available by hospital discharge of the mother: 1. Induction to delivery interval 2. Mode of delivery 3. Neonatal outcome (admission, umbilical cord blood pH, Apgar score) 4. Analgesia use in labour 5. Cardiotocographic abnormalities in labour (tachysystole, hyperstimulation) 6. Meconium stained liquor 7. Blood loss during labour and delivery 8. Maternal fever (any maternal temperature greater than or equal to 38°C during labour or postpartum before discharge)

Countries

Malaysia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026